Impact of the Antiplatelet Strategy Following Patent Foramen Ovale Percutaneous Closure.
Roxana MehranJulio Iván Farjat PasosGabriel AssloVincent RouleFarzin BeyguiAlexis HermidaPaul GabrionLaurent LeborgneDr Christine HoudeFlorent HuangBenoit LattucaFlorence LeclercqJules MesnierJeremie AbtanStéphanie RouanetNadjib HammoudiJean Philippe ColletMichel ZeitouniJohanne SilvainGilles MontalescotJosep Rodes-Cabaunull nullPublished in: European heart journal. Cardiovascular pharmacotherapy (2023)
The antiplatelet strategy following PFO closure did not seem to impact clinical outcomes, thus challenging the current recommendations of temporary DAPT.